Table 1.
Demographic and clinical characteristics of the participants
| Variables | All (n = 87) |
|---|---|
| Age (years) | 37.67 (7.53) |
| Gender (female/male) | 2/85 |
| Education (years) | 12.51 (3.2) |
| Age at first experience (years) | 20.55 (5.65) |
| Age at addiction (years) | 28.62 (8.8) |
| Cocaine use 30 days before baseline (n. of days; %) | 19.17 (11.45) |
| Daily | 47% |
| Weekly | 33% |
| Monthly | 20% |
| rTMS sessions number | 29.17 (6.34) |
| PSQI score ≥ 5 at baseline [%] | 88.5 |
| CCQ score at baseline | 12.66 (10.93) |
| BDI-II score at baseline | 18.98 (9.91) |
| SAS score at baseline | 47.93 (10.01) |
| GSI score at baseline | 65.91 (16.53) |
Data are presented as mean (standard deviation), unless otherwise specified. BDI-II Beck Depression Inventory-II; CCQ Cocaine Craving Questionnaire; GSI Global Severity Index of the Symptoms checklist 90 - Revised; PSQI Pittsburgh Sleep Quality Index; rTMS repetitive Transcranial Magnetic Stimulation; SAS Self-rating Anxiety Scale